S&P 500
5,985.96
+0.3%
+$15.59
DJI
42,584.67
+0.2%
+$65.03
NASDAQ
19,478.50
+0.4%
+$79.54
Bitcoin
105,345.00
-0.7%
-700.28
AAPL
$203.25
-0.0%
-$0.02
AMZN
$207.66
+0.9%
+$1.95
GOOG
$168.89
+0.7%
+$1.18
META
$683.40
+2.5%
+$16.55
MSFT
$464.65
+0.4%
+$1.68
NVDA
$141.02
-0.1%
-$0.20
TSLA
$333.99
-3.0%
-$10.28
Fennec Pharmaceuticals (NASDAQ: FENC)
$7.73
(-1.8%)
-$0.14
Price as of June 4, 2025, 1:41 p.m. ET
Fennec Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Fennec Pharmaceuticals Company Info
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.